Skip to main content
. Author manuscript; available in PMC: 2023 Sep 1.
Published in final edited form as: Leuk Lymphoma. 2022 Jun 1;63(9):2126–2135. doi: 10.1080/10428194.2022.2062347

Fig 2. CONSORT diagram of clinical trial enrollment and treatment.

Fig 2.

ASCT, autologous stem cell transplantation; L, lenalidomide; Ld, lenalidomide plus low-dose dexamethasone; Ld+ASCT, Ld induction followed by early ASCT; PD, progressive disease; PR, partial response; SD, stable disease.